Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications
Open accessThe DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
Induced pluripotent stem cells (iPSCs) are a type of pluripotent stem cells generated directly from mature cells through the introduction of key transcription factors. iPSCs can be propagated and differentiated into many cell types in the human body, holding enormous potential in the field of regenerative medicine. However, genomic instability of iPSCs has been reported with the advent of high-throughput technologies such as next-generation sequencing. The presence of genetic variations in iPSCs has raised serious safety concerns, hampering the advancement of iPSC-based novel therapies. Here we summarize our current knowledge on genomic instability of iPSCs, with a particular focus on types of genetic variations and their origins. Importantly, it remains elusive whether genetic variations in iPSCs can be an actual risk factor for adverse effects including malignant outgrowth. Furthermore, we discuss novel approaches to generate iPSCs with fewer genetic variations. Lastly, we outline the safety issues and monitoring strategies of iPSCs in clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, these iPSC models encounter significant reproducibility challenges. When in a pluripotent state, they are highly sensitive to external environmental cues, modifying internal genomic architecture, becoming unsuitable for differentiations11.”
From Examining iPSC derived motor neuron variability and genome stability monitoring as a solution (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Following previous studies in the literature, it is known that iPSC genomic architecture can change over time whilst these cells are in culture11 and this can have a noticeable impact on differentiation protocols21.”
From Examining iPSC derived motor neuron variability and genome stability monitoring as a solution (2025) · cites this paper as [11]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, variability in differentiation outcomes presents a major barrier to reproducibility and model reliability.”
From Examining iPSC derived motor neuron variability and genome stability monitoring as a solution (2025) · cites this paper as [11]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 2×
“Since the establishment of human iPSCs in 2007 [2, 3], many attempts have been made to produce iPSCs more efficiently and safely.”
BackgroundThe cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Sequencing technologies – the next generation
Metzker, M. L. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2626 · Cited by 7,066 · cited 1×
“netic variations across the entire genome at single nucleotide resolution [17] and (ii) low frequency variations which could not be identified by conventional methods [18], revolutionizing the field of genomic research including genomic studies of iPSCs.”
BackgroundAge-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841 · cited 1×
“Somatic mutations, including cancer driver mutations, have been shown to accumulate in blood cells with increasing age [70, 71].”
BackgroundThe pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686 · cited 1×
“[47] for review) Tumorigenic potential might also differ depending on the environment [48] surrounding the transplanted cells.”
BackgroundComing of age: ten years of next-generation sequencing technologies
Goodwin, S., McPherson, J. D., & McCombie, W. R. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.49 · Cited by 4,352
Cited by
Ethical and Safety Issues of Stem Cell-Based Therapy
Volarevic, V., Markovic, B. S., Gazdic, M., Volarevic, A., Jovicic, N., Arsenijevic, N., Armstrong, L., Djonov, V., Lako, M., & Stojkovic, M. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.21666 · Cited by 876
Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications
Liu, G., David, B. T., Trawczynski, M., & Fessler, R. G. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09935-x · Cited by 519
Modeling Alzheimer’s disease with iPSC-derived brain cells
Penney, J., Ralvenius, W. T., & Tsai, L.-H. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0468-3 · Cited by 471
Glis1 facilitates induction of pluripotency via an epigenome–metabolome–epigenome signalling cascade
Li, L., Chen, K., Wang, T., Wu, Y., Xing, G., Chen, M., Hao, Z., Zhang, C., Zhang, J., Ma, B., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0267-9 · Cited by 315
Stem Cell Therapy in Heart Diseases – Cell Types, Mechanisms and Improvement Strategies
Müller, P., Lemcke, H., & David, R. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000492704 · Cited by 215
Metadata
- Authors
- Yoshihara, M., Hayashizaki, Y., & Murakawa, Y.
- Affiliations
- RIKEN (JP)
- Corresponding author
- Murakawa, Yasuhiro
- Venue
- Stem Cell Reviews and Reports
- Published
- 2016-09-05
- Volume
- 13
- Issue
- 1
- Pages
- 7-16
- ISSN
- 1550-8943 (ISSN-L)
- 1558-6804
- PMC
- PMC5346115
- OpenAlex
- W2510668402
- Cited by
- 283
- References
- 119
- Citations by year
- 2026: 13 · 2025: 26 · 2024: 26 · 2023: 19 · 2022: 28 · 2021: 47 · 2020: 34 · 2019: 32 · 2018: 27 · 2017: 28 · 2016: 3
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Stem Cell Reviews and Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science, and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- induced pluripotent stem cells, genomic instability, genetic variation, somatic mutations, iPSC safety, iPSC-based therapy, clinical translation
- MeSH terms
- Cell Differentiation, Humans, Models, Genetic, Risk Factors, Transcription Factors, Genetic Variation, Stem Cell Transplantation, Genomic Instability, Induced Pluripotent Stem Cells, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications. https://app.cochat.ai/papers/10.1007/s12015-016-9680-6
- The paper
- Yoshihara, M., Hayashizaki, Y., & Murakawa, Y. (2017). Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications. Stem Cell Reviews and Reports. https://doi.org/10.1007/s12015-016-9680-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.